14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
SLMT vs ACET: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, SLMT (SLMT) is the stronger overall head-to-head candidate over Adicet Bio, Inc. (ACET) in the Tradestie Institutional Equity Comparison Engine, winning 3–3 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Options & Positioning). SLMT carries a Unified Composite Score of 43.0/100 (HOLD) at $2.24 (N/M Forward P/E, -4271.3% operating margin), whereas ACET carries 40.1/100 (SELL) at $2.14 (N/M Forward P/E, 0.0% operating margin).
Technical & Structure Timing Caution: SLMT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.7); meanwhile ACET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 13.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SLMT vs ACET. Trailing 12-month operating profitability (SLMT -4271.3% vs ACET 0.0%) and valuation multiples (SLMT N/M vs ACET N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Biotechnology value chain with $23.0M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ SLMT vs ACET Key Questions & Quantitative Answers
As of Nov 20, 2026, SLMT (SLMT) is the stronger overall head-to-head candidate over Adicet Bio, Inc. (ACET) in the Tradestie Institutional Equity Comparison Engine, winning 3–3 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Options & Positioning). SLMT carries a Unified Composite Score of 43.0/100 (HOLD) at $2.24 (N/M Forward P/E, -4271.3% operating margin), whereas ACET carries 40.1/100 (SELL) at $2.14 (N/M Forward P/E, 0.0% operating margin). Technical & Structure Timing Caution: SLMT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.7); meanwhile ACET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 13.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SLMT leads the Growth & Scale pillar: SLMT posts +929.8% YoY revenue growth and +0.0% YoY earnings growth on $7.3M TTM revenue (100.0% gross margin, -4271.3% operating margin), compared with ACET at -100.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, SLMT generates $7.3M in USD-normalized revenue versus N/A for ACET. In operating R&D and SG&A reinvestment, SLMT deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ACET.
SLMT and ACET trade at balanced relative valuation multiples. SLMT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.9x EV/Revenue (unreported EBITDA margin), whereas ACET trades at N/M Forward P/E, N/M Trailing P/E, 0.82x PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SLMT (-795.8% ROE) versus ACET (-85.9% ROE) capital efficiency.
In options market volatility and institutional positioning, SLMT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (7.98β · 107% Vol realized risk). By comparison, ACET carries 230.4% implied volatility (27th %ile, Balanced (25th–60th %ile)), a 1.41x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.93β · 60% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.